Press ReleaseView printer-friendly version << Back
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
New No Fingerstick1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System
"We look forward to having multiple ways to help our patients manage their diabetes as we know that patient needs and preferences can vary greatly," said Prof.
The InPen is the first and only smart insulin pen approved in
For individuals who prefer automated insulin delivery via an insulin pump, the MiniMed 780G system with Guardian 4 sensor will automatically adjust and correct insulin delivery every 5 minutes with no fingersticks5. By pairing the MiniMed 780G system with the recently launched Medtronic Extended infusion set that is indicated for up to 7 days, twice as long as current infusion sets, insulin pump users may need to perform 70 fewer set changes per year6. With these two innovations, Medtronic offers the only pump that adjusts and corrects every 5 minutes with an infusion set that lasts twice as long –improving the experience of using insulin pump therapy.
"We know that diabetes is a very personal journey, and we want to meet people where they are with solutions that fit their lifestyle and needs while enabling them to experience seamless support through all their life transitions. That's why we've made the commitment to expand our portfolio and prioritize what matters most to our customers — a technology experience that's easy but doesn't compromise the outcomes they deliver," said
About the Diabetes Business at Medtronic (www.medtronicdiabetes.com)
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the
1 If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
2 Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
3 Guardian™ 4 sensor is the commercial name of "Zeus" sensor in development from Medtronic.
4 Data may not appear or be delayed in certain instances, including when there is no internet connection. A confirmatory fingerstick is required prior to making adjustments to diabetes therapy.
5 If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. BG needed when SmartGuard™ is first initiated.
6 Assumes 122 set changes for standard infusion sets and 52 set changes per year for the extended wear infusion set
View original content to download multimedia:http://www.prnewswire.com/news-releases/medtronic-secures-two-ce-mark-approvals-for-guardian-4-sensor--for-inpen-mdi-smart-insulin-pen-301299392.html